These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25332170)

  • 21. Phosphopeptide enrichment with TiO2-modified membranes and investigation of tau protein phosphorylation.
    Tan YJ; Sui D; Wang WH; Kuo MH; Reid GE; Bruening ML
    Anal Chem; 2013 Jun; 85(12):5699-706. PubMed ID: 23638980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of in vivo phosphorylation sites of lens proteins from porcine eye lenses by a gel-free phosphoproteomics approach.
    Chiou SH; Huang CH; Lee IL; Wang YT; Liu NY; Tsay YG; Chen YJ
    Mol Vis; 2010 Feb; 16():294-302. PubMed ID: 20182557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Exfoliated 2D Egyptian Blue Nanosheet for Highly Selective Enrichment of Multi-phosphorylated Peptides in Mass Spectrometric Analysis.
    Yang SS; Yu HX; Wang ZZ; Liu HL; Zhang H; Yu X; Shang W; Chen GQ; Gu ZY
    Chemistry; 2018 Feb; 24(9):2109-2116. PubMed ID: 29071782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.
    Di Domenico F; Sultana R; Barone E; Perluigi M; Cini C; Mancuso C; Cai J; Pierce WM; Butterfield DA
    J Proteomics; 2011 Jun; 74(7):1091-103. PubMed ID: 21515431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.
    Hanger DP; Betts JC; Loviny TL; Blackstock WP; Anderton BH
    J Neurochem; 1998 Dec; 71(6):2465-76. PubMed ID: 9832145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role.
    Ho GJ; Hashimoto M; Adame A; Izu M; Alford MF; Thal LJ; Hansen LA; Masliah E
    Neurobiol Aging; 2005 May; 26(5):625-35. PubMed ID: 15708437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
    Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
    Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative phosphoproteomics studies using stable isotope dimethyl labeling coupled with IMAC-HILIC-nanoLC-MS/MS for estrogen-induced transcriptional regulation.
    Wu CJ; Chen YW; Tai JH; Chen SH
    J Proteome Res; 2011 Mar; 10(3):1088-97. PubMed ID: 21210654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
    Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S
    Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau as a therapeutic target for Alzheimer's disease.
    Boutajangout A; Sigurdsson EM; Krishnamurthy PK
    Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic Profiling of Mouse Brains Exposed to Blast-Induced Mild Traumatic Brain Injury Reveals Changes in Axonal Proteins and Phosphorylated Tau.
    Chen M; Song H; Cui J; Johnson CE; Hubler GK; DePalma RG; Gu Z; Xia W
    J Alzheimers Dis; 2018; 66(2):751-773. PubMed ID: 30347620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
    Russell CL; Mitra V; Hansson K; Blennow K; Gobom J; Zetterberg H; Hiltunen M; Ward M; Pike I
    J Alzheimers Dis; 2017; 55(1):303-313. PubMed ID: 27636850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoprobe-based immobilized metal affinity chromatography for sensitive and complementary enrichment of multiply phosphorylated peptides.
    Wu HT; Hsu CC; Tsai CF; Lin PC; Lin CC; Chen YJ
    Proteomics; 2011 Jul; 11(13):2639-53. PubMed ID: 21630456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and application of a phosphoproteomic method using electrostatic repulsion-hydrophilic interaction chromatography (ERLIC), IMAC, and LC-MS/MS analysis to study Marek's Disease Virus infection.
    Chien KY; Liu HC; Goshe MB
    J Proteome Res; 2011 Sep; 10(9):4041-53. PubMed ID: 21736374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of immunoprecipitation - two-dimensional liquid chromatography - mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients.
    Bijttebier S; Theunis C; Jahouh F; Martins DR; Verhemeldonck M; Grauwen K; Dillen L; Mercken M
    J Chromatogr A; 2021 Aug; 1651():462299. PubMed ID: 34107398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
    Ferrer I
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
    Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
    J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.